These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35000532)

  • 41. Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.
    Tribius S; Haladyn S; Hanken H; Busch CJ; Krüll A; Petersen C; Bergelt C
    Strahlenther Onkol; 2021 Mar; 197(3):219-230. PubMed ID: 33377992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
    Nuyts S; Lambrecht M; Duprez F; Daisne JF; Van Gestel D; Van den Weyngaert D; Platteaux N; Geussens Y; Voordeckers M; Madani I; De Neve W
    Radiother Oncol; 2013 Nov; 109(2):323-9. PubMed ID: 23953410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
    Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
    J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
    Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life.
    van Rij CM; Oughlane-Heemsbergen WD; Ackerstaff AH; Lamers EA; Balm AJ; Rasch CR
    Radiat Oncol; 2008 Dec; 3():41. PubMed ID: 19068126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
    Zhou J; Fei D; Wu Q
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Dosimetric Parameters in Dysphagia Aspiration-Related Structures and Clinical Correlation in Head and Neck Cancer Patients Treated With Radiotherapy.
    Upadhyay P; Kumar P; Chauhan AK; Kumar P; Nigam J; S N
    Cureus; 2022 Jul; 14(7):e26765. PubMed ID: 35967135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
    Lambrecht M; Nevens D; Nuyts S
    Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans.
    Schmidt M; Lo JY; Grzetic S; Lutzky C; Brizel DM; Das SK
    Med Phys; 2015 Aug; 42(8):4428-34. PubMed ID: 26233173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    MacFarlane M; Hoover DA; Wong E; Read N; Palma D; Venkatesan V; Hammond A; Battista JJ; Chen JZ
    Radiother Oncol; 2016 May; 119(2):331-6. PubMed ID: 27041142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.
    Magnuson WJ; Urban E; Bayliss RA; Harari PM
    Technol Cancer Res Treat; 2015 Jun; 14(3):315-9. PubMed ID: 25782188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetric analytic comparison of inverse and forward planned IMRT techniques in the treatment of head and neck cancer.
    Nasr A; Habash A
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):119-25. PubMed ID: 25150127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
    Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective study.
    Hoyne C; Dreosti M; Shakeshaft J; Baxi S
    J Med Radiat Sci; 2017 Jun; 64(2):125-130. PubMed ID: 28240447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxicities and clinical outcome of adjuvant dysphagia optimized versus standard intensity-modulated radiotherapy for post-operative oral cavity cancers: A prospective comparative study.
    Patni A; Rastogi M; Gandhi AK; Mishra VK; Srivastava AK; Sharma V; Agarwal A; Khurana R; Hadi R; Sapru S; Mishra SP
    Head Neck; 2023 Dec; 45(12):3119-3128. PubMed ID: 37814926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
    Tol JP; Doornaert P; Witte BI; Dahele M; Slotman BJ; Verbakel WF
    Radiother Oncol; 2016 May; 119(2):337-43. PubMed ID: 27130730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.